Favorable Adherence and Tolerability of Letermovir Versus Valganciclovir for Cytomegalovirus Prophylaxis in Kidney Transplant Recipients Aged 65 y or Older: Findings From a Randomized, Phase 3 Trial

By afschroeder • August 26, 2026

Bunnapradist S, Vincenti F, Witzke O, Schneeberger S, Nguyen MH, Broyde N, Gilbert CL, Haber B. Favorable Adherence and Tolerability of Letermovir Versus Valganciclovir for Cytomegalovirus Prophylaxis in Kidney Transplant Recipients Aged 65 y or Older: Findings From a Randomized, Phase 3 Trial. Transplant Direct. 2026 Aug 21;12(9):e1990. doi: 10.1097/TXD.0000000000001990. PMID: 42639594; PMCID: PMC13502855.

Tags: Nephrology, Publications

Obesity and Cardio-Metabolic Health in Kidney Disease: Implications for Kidney Health, Risk Stratification, and Management

Mathew RO, Hong A, Narasaki Y, Fung E, Cheung D, Han J, Durstenfeld MS, Hsue PY, Rhee CM. Obesity and Cardio-Metabolic Health in Kidney Disease:[...]

Enhancing Evidence Generation by Linking Randomized Clinical Trials to Real-World Data: The INVESTED-Medicare Linkage Study

Cho H, Shin H, Najafzadeh M, Claggett B, Ortega-Montiel J, Liu J, Paik JM, Lalani NF, Bradley MC, Concato J, Solomon SD, Vardeny O, Patorno[...]

Comparative Short-term Risk of Severe Gastrointestinal Events Associated With Opioid Type Among Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists

Bea S, Patorno E, Sreedhara SK, Wexler DJ, Cromer SJ, Glynn RJ, Paik JM, Bykov K. Comparative Short-term Risk of Severe Gastrointestinal Events Associated With[...]